Register for IndieBio New York’s Investor Showcase – March 11, 2026

Chronos DX

Giving people more time.

Team

James Tyrrell

Co-Founder

Ella Mi

Co-Founder

Company details

ChronosDx has developed an ultrasensitive and scalable bioassay technology for early disease detection, based on proprietary organic semiconductor technology. Their sensors have achieved world leading attomolar sensitivity, 100,000x superior to state-of-the-art immunoassay, enabling them to pick up diseases like cancer in its early stages when it is undetectable by other technologies.

Get In Touch with Chronos DX

Please tell us a little bit about yourself and why you'd like to get connected. Chronos DX + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.